Iofina to produce less of iodine derivative after China imposes tariff
Published: Tuesday, 30 October 2018
Iofina’s CEO rejects claims that the company has approached North American companies with cut-price derivatives after an anti-dumping tariff was enacted in China, and says that the company has instead focused its sales efforts on raw iodine.
Iodine producer Iofina will focus its efforts on selling raw
iodine after an iodine derivative product was made subject to a
significant anti-dumping tax by China, so that sales to the
East Asian nation are no longer viable.
US-produced iodine derivative hydriodic acid (HI) was
recently assessed as being subject...